Trial intelligence / Profile preview

Lidocaine laryngotracheal anesthesia for pediatric rigid bronchoscopy

IRCT20100527004041N21Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lidocaine in airway disorder (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Ease of bronchoscopy, Blood pressure and 2 more. Started May 2020; status: completed.

02

Drugs

lidocaine
03

Conditions

airway disorder

Beyond the preview

Go deeper on IRCT20100527004041N21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100527004041N21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call